Ellen AB Logo

Ellen AB

Develops research-based probiotic and prebiotic products for women's intimate health and pH balance.

ELN | ST

Overview

Corporate Details

ISIN(s):
SE0014730347
LEI:
549300KJGSYJ46ZTZ557
Country:
Sweden
Address:
Barnhusgatan 4 ög nv, 111 23 Stockholm
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ellen AB is a biotechnology and Fem-Tech company, founded in 2000, that specializes in women's intimate health. The company develops and markets a range of innovative and natural products designed to maintain a healthy pH balance for women throughout all stages of life, including menstruation, pregnancy, and menopause. Ellen's offerings are grounded in scientific research and its portfolio includes products such as probiotic tampons, which contain the patented strain of lactic acid bacteria Lacto Naturel (LN), as well as prebiotic cleansers, probiotic creams, and vaginal pH tests. The company's mission is to provide effective, research-based solutions that contribute to women's well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ellen AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ellen AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ellen AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BRISTOL MYERS SQUIBB CO Logo
Develops innovative medicines for oncology, immunology, and cardiovascular diseases.
United States of America
BMY
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
South Korea
003000
C4 Therapeutics, Inc. Logo
Developing protein degrader medicines to treat cancer and other serious diseases.
United States of America
CCCC
Cadrenal Therapeutics, Inc. Logo
Developing novel anticoagulant therapies for high-risk cardiovascular patients.
United States of America
CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for critical illnesses like acute pancreatitis & AKI.
United States of America
CALC
Calidi Biotherapeutics, Inc. Logo
Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.
United States of America
CLDI
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden
CALTX
CALTH. Inc Logo
Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.
South Korea
402420
Cambrex Logo
United States of America
CBM
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom
CNSL

Talk to a Data Expert

Have a question? We'll get back to you promptly.